InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Harlan Robins. Director active across 1 company, notably Adaptive Biotechnologies Corporation. Cumulatively, 8 disclosures have been logged. History available since 15 June 2026. The latest transaction was filed on 20 August 2026 (Notice of proposed sale (Form 144)). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations
Harlan Robins is a declarant associated with Adaptive Biotechnologies Corporation, where he is listed as Former Officer. He has 7 filings in total, and in the recent filings available they relate to sales, with EUR 35,217,076 in total, from 2026-06-15 to 2026-08-19, with the most common transaction nature being Notice of proposed sale (Form 144).